{
    "sec_cik": "0000872589",
    "sec_company_name": "REGENERON PHARMACEUTICALS INC (Filer)",
    "document_type": "8K",
    "sec_form_header": "Form 8-K",
    "sec_period_of_report": "20170209",
    "sec_filing_date": "20170209",
    "sec_changed_date": "20170209",
    "sec_accepted_date": "20170209071639",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/872589/000153217617000006/0001532176-17-000006-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/872589/000153217617000006/0001532176-17-000006.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0006\003\REGN_0000872589_8K_20170209_8-K_metadata.json",
    "original_file_name": "file was not saved locally",
    "original_file_size": "30183 chars",
    "document_group": "8-K",
    "section_name": "8-K",
    "section_n_characters": 2238,
    "endpoints": [
        "Document   ",
        "99.1Press Release, dated February 9, 2017, Reporting Fourth Quarter and Full Year 2016 Financial and Operating Results."
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "REGN",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0006\003\REGN_0000872589_8K_20170209_8-K_excerpt.txt",
    "time_elapsed": 0.0,
    "batch_number": 6,
    "batch_signature": "",
    "batch_start_time": "2023-04-16 22:00:52.115412",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-16 22:09:51.811818"
}